Literature DB >> 35958526

Importance of bicuspid aortic valve phenotype on aortopathy.

Evaldas Girdauskas1, John A Elefteriades2.   

Abstract

Entities:  

Year:  2022        PMID: 35958526      PMCID: PMC9357954          DOI: 10.21037/acs-2022-bav-16

Source DB:  PubMed          Journal:  Ann Cardiothorac Surg        ISSN: 2225-319X


× No keyword cloud information.

Introduction

The heterogeneity of aortopathy associated with bicuspid aortic valve (BAV) remains a diagnostic and therapeutic challenge, despite several decades of exponential clinical and experimental research in this field. The interaction of congenital and hemodynamic factors plays a competing role in the aortopathy progression and hinders thereby the clinical prediction modelling. Nonetheless, several phenotypic features of BAV are associated with specific aortopathy patterns and may, therefore, guide our clinical decisions. This editorial article briefly summarizes the published associations between BAV phenotype and the concomitant aortopathy.

BAV cusp fusion pattern and aortopathy

Several observational studies described an empirical association between BAV cusp fusion pattern and the associated aortopathy. The most common pattern of the right and left coronary cusp fusion in BAV (i.e., BAV R/L) was linked to a more proximal type of aortopathy (i.e., dilatation of the sinus of Valsalva and of the proximal ascending aorta) as compared to the right coronary–non-coronary morphotype of BAV (i.e., BAV R/N) (1). On the contrary, BAV R/N was associated with a more distal form of aortopathy, limited to the distal ascending aorta and the proximal aortic arch, without involving the aortic root (1). These differences in the aortopathy shape might result from distinct transvalvular flow patterns in the different BAV cusp fusion patterns. Such transvalvular flow differences in distinct cusp fusion patterns were convincingly demonstrated by sophisticated 4D-flow cardiac magnetic resonance imaging (cMRI). This data supports the hemodynamic origin of BAV-associated aortopathy (2). Another evidence of hemodynamic impact has been the reported relationship between increased regional wall shear stress by 4D cMRI and regional aortic tissue remodeling (i.e., extracellular matrix dysregulation and elastic fiber degeneration) (3). These findings implicate BAV-related hemodynamics as a contributing factor in the development of aortopathy. However, there is some discordant data regarding BAV phenotype and the concomitant aortopathy. Of note, symmetric BAV valves (i.e., Sievers type 0) have been shown to result in an almost central, laminar transvalvular flow pattern, without relevant rheological disturbances. However, type 0 BAV’s are frequently associated with a root-type aortopathy, which cannot be explained by deleterious transvalvular hemodynamics. Furthermore, quite a few very asymmetric type I BAV’s with a resultant eccentric, deleterious transvalvular flow have a completely normal proximal aorta and never develop clinically relevant aortopathy (4). Such clinical observations reveal obvious limitations of the hemodynamic/rheologic theory and turn our attention toward congenital factors. In line with the congenital hypothesis, previous experimental work provided valid data showing that R/N BAVs and R/L BAVs may have different etiologies and result from distinct morphogenetic defects during embryogenesis (5). Furthermore, BAV morphotype, i.e., R/N BAV vs. R/L BAV, seems to be an important determinant of the elastic properties and dimensions of the aorta (6). Moreover, R/L BAVs have a more severe degree of aortic wall degeneration than R/N BAVs and are significantly more frequently associated with coarctation of the aorta. These data suggest that the congenital factors that determine the formation of R/N and R/L BAV may also be involved in the occurrence and the progression of BAV-associated aortopathy.

Type of BAV dysfunction and aortopathy

Another important observation regarding BAV phenotype and the associated aortopathy is the reported correlation between type of BAV dysfunction and the phenotype of aortopathy. Della Corte and co-authors were the first to describe the ascending phenotype and the root phenotype that are associated with different baseline patient characteristics, specific histological changes in the aortic wall and grossly distinct natural history/clinical outcome (7). Patients with ascending phenotype present mostly in older age with a typical BAV stenosis and dilatation of the mid-ascending aorta, without relevant root involvement; they have a benign clinical course after an isolated aortic valve replacement (8). The extent of mid-ascending dilatation is proportional to the severity of aortic valve stenosis, which implicates the predominantly hemodynamic origin of ascending phenotype (7). On the other hand, root-phenotype represents a completely different form of BAV-associated aortopathy. Root phenotype is predominantly found in young men and occurs in combination with Marfan-like characteristics, indicating a congenital connective tissue disorder. Root phenotype presents as an isolated, predominantly aortic root dilatation with concomitant aortic regurgitation or a normally functioning aortic valve (7). Of note, such BAV patients have a much higher risk of late aortic events after an isolated aortic valve surgery, indicating the predominance of congenital aortic wall disease. Indeed, a wide spectrum of genetic abnormalities was found in the cohort of BAV patients presenting with a root phenotype (9). Aortic regurgitation in BAV patients with a root-phenotype seems a secondary phenomenon rather than an independent pathogenetic entity in the scenario of the progressive root dilatation. Our hypothesis that aortic regurgitation in BAV is associated with a more malignant form of aortopathy is supported by a meta-analysis demonstrating a 10-fold higher risk of type A aortic dissection after an isolated aortic valve replacement in patients with aortic regurgitation vs. aortic stenosis (10).

Conclusions

In summary, the available literature provides some evidence that distinct BAV phenotypes may be associated with specific forms of bicuspid aortopathy. However, there is still no robust evidence of causality between BAV phenotype and the concomitant aortopathy. Hemodynamic disturbances caused by eccentric transvalvular flow patterns in BAV play a role and may partially explain the development of aortopathy. However, other forms of BAV aortopathy (e.g., root phenotype) seem to progress independent of any hemodynamic disturbances; highlighting the relevance of congenital factors as well. Thus, the concomitant BAV phenotype may represent only a silent bystander in complex congenital aortic root disease.
  10 in total

1.  Aortic Dissection After Previous Aortic Valve Replacement for Bicuspid Aortic Valve Disease.

Authors:  Evaldas Girdauskas; Mina Rouman; Kushtrim Disha; Andres Espinoza; Martin Misfeld; Michael A Borger; Thomas Kuntze
Journal:  J Am Coll Cardiol       Date:  2015-09-22       Impact factor: 24.094

2.  Bicuspid aortic valves with different spatial orientations of the leaflets are distinct etiological entities.

Authors:  Borja Fernández; Ana C Durán; Teresa Fernández-Gallego; M Carmen Fernández; Miguel Such; Josep M Arqué; Valentín Sans-Coma
Journal:  J Am Coll Cardiol       Date:  2009-12-08       Impact factor: 24.094

3.  Association between leaflet fusion pattern and thoracic aorta morphology in patients with bicuspid aortic valve.

Authors:  Bryce A Merritt; Alexander Turin; Michael Markl; S Chris Malaisrie; Patrick M McCarthy; James C Carr
Journal:  J Magn Reson Imaging       Date:  2013-11-04       Impact factor: 4.813

4.  Risk of late aortic events after an isolated aortic valve replacement for bicuspid aortic valve stenosis with concomitant ascending aortic dilation.

Authors:  Evaldas Girdauskas; Kushtrim Disha; Heinrich H Raisin; Maria-Anna Secknus; Michael A Borger; Thomas Kuntze
Journal:  Eur J Cardiothorac Surg       Date:  2012-03-30       Impact factor: 4.191

5.  Genetic abnormalities in bicuspid aortic valve root phenotype: preliminary results.

Authors:  Evaldas Girdauskas; Lisa Geist; Kushtrim Disha; Iliaz Kazakbaev; Tatiana Groß; Solveig Schulz; Martin Ungelenk; Thomas Kuntze; Hermann Reichenspurner; Ingo Kurth
Journal:  Eur J Cardiothorac Surg       Date:  2017-07-01       Impact factor: 4.191

6.  Usefulness of bicuspid aortic valve phenotype to predict elastic properties of the ascending aorta.

Authors:  Benjamin M Schaefer; Mark B Lewin; Karen K Stout; Peter H Byers; Catherine M Otto
Journal:  Am J Cardiol       Date:  2007-01-05       Impact factor: 2.778

7.  Predictors of ascending aortic dilatation with bicuspid aortic valve: a wide spectrum of disease expression.

Authors:  Alessandro Della Corte; Ciro Bancone; Cesare Quarto; Giovanni Dialetto; Franco E Covino; Michelangelo Scardone; Giuseppe Caianiello; Maurizio Cotrufo
Journal:  Eur J Cardiothorac Surg       Date:  2007-01-22       Impact factor: 4.191

8.  Are normal-sized ascending aortas at risk of late aortic events after aortic valve replacement for bicuspid aortic valve disease?

Authors:  Kushtrim Disha; Mina Rouman; Maria-Anna Secknus; Thomas Kuntze; Evaldas Girdauskas
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-01-23

9.  Bicuspid aortic cusp fusion morphology alters aortic three-dimensional outflow patterns, wall shear stress, and expression of aortopathy.

Authors:  Riti Mahadevia; Alex J Barker; Susanne Schnell; Pegah Entezari; Preeti Kansal; Paul W M Fedak; S Chris Malaisrie; Patrick McCarthy; Jeremy Collins; James Carr; Michael Markl
Journal:  Circulation       Date:  2013-12-17       Impact factor: 29.690

10.  Valve-Related Hemodynamics Mediate Human Bicuspid Aortopathy: Insights From Wall Shear Stress Mapping.

Authors:  David G Guzzardi; Alex J Barker; Pim van Ooij; S Chris Malaisrie; Jyothy J Puthumana; Darrell D Belke; Holly E M Mewhort; Daniyil A Svystonyuk; Sean Kang; Subodh Verma; Jeremy Collins; James Carr; Robert O Bonow; Michael Markl; James D Thomas; Patrick M McCarthy; Paul W M Fedak
Journal:  J Am Coll Cardiol       Date:  2015-08-25       Impact factor: 24.094

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.